Escolar Documentos
Profissional Documentos
Cultura Documentos
discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/225277727
CITATIONS
READS
56
5 authors, including:
Sheng-Mou Hsiao
Ho-Hsiung Lin
SEE PROFILE
SEE PROFILE
Ming-Chow Wei
Far Eastern Memorial Hospital
11 PUBLICATIONS 57 CITATIONS
SEE PROFILE
bs_bs_banner
doi:10.1111/j.1447-0756.2012.01901.x
434..436
Abstract
Borderline ovarian tumor with the initial presentation of pseudo-Meigs syndrome is rare. A 52-year-old
postmenopausal woman presented with a large ovarian tumor, ascites, and right hydrothorax. We found
elevated serum carcinoembryonic antigens (44.4 ng/mL), carbohydrate antigen (CA)-125 (269.8 U/mL), and
CA-199 (7942 U/mL). The frozen section pathology revealed a mucinous borderline ovarian tumor, and a
staging operation was performed. Final pathologic examination confirmed the diagnosis of intestinal type
ovarian mucinous borderline tumor with non-invasive cul-de-sac implants. Her pleural effusion and ascites
resolved after surgery, and she remained tumor-free after 3 years follow up. Physicians should be cautious for
the rare possibility of pseudo-Meigs syndrome in patients with pelvic tumors having the features of advanced
ovarian cancer.
Key words: borderline ovarian tumor, pleural effusion, pseudo-Meigs syndrome.
Introduction
Borderline ovarian tumor (BOT) is defined histologically by atypical epithelial proliferation without
stromal invasion.1 Fourteen to twenty-six percent
of patients with BOT were found to have ascites in
their initial presentations.2,3 However, pleural effusion
has rarely been reported in patients with BOT.4 We
report a rare case of mucinous BOT with pseudoMeigs syndrome and elevated carbohydrate antigen
(CA)-125.
Case Report
A 52-year-old postmenopausal woman, single, gravida
0, para 0, visited our outpatient clinics with the complaints of progressive dyspnea and abdominal distension within 5 months. Ultrasound examination and
434
Discussion
Disclosure
None of the authors has anything to disclose.
References
non-invasive cul-de-sac implants (Fig. 2). The patients
postoperative course was uneventful. Her pleural
effusion and ascites were resolved; she remained
tumor-free after 3 years follow up.
435
436